Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Benchmark Plus opens its HFRI Equity Long/Short Tracking Fund to outside investors

Thursday, September 20, 2012

amb
Mike Mikytuck
Bailey McCann, Opalesque New York:

Benchmark Plus Management, a private alternative investment firm with $1.6bn in assets under management, has begun accepting outside investors into its Benchmark Plus HFRI Equity HedgeTRAX fund. The fund is designed to track the HFRI Equity Hedge (Total) index, which represents roughly 1,400 equity long/short hedge fund managers. The fund is part of Benchmark's overall equity long/short sleeve, which has $211M in assets.

The fund is designed to provide institutional investors with broad-based exposure to the most widely recognized, but non-investable, equity long/short benchmark. Benchmark Plus utilizes its Real AlphaTM process to evaluate and replicate the index’s return drivers including betas, factors and alpha. From its inception in January 2011, HFRI Equity HedgeTRAX has successfully demonstrated a 99+% correlation to the index.

"When we launched in January 2011, no one had really created a fund tracking the HFRI Equity Long/Short index. HFRI is used by most investors as a comparable benchmark, over the HFRX which our research showed doesn't always track accurately," explains Mike Mikytuck, Managing Director, Benchmark Plus in an interview with Opalesque.

The Index is offered in a limited partnership format with quarterly liquidity, making for a slightly different take on an index product. According to Mikytuck, this format allows them to include an alpha component, realized by underlying allocat......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its